Cyclobenzaprine Hydrochloride
Product Images NDC 53002-0520

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 53002-0520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Figure 01 Chemical Structure)

Chemical Structure (Figure 01 Chemical Structure)
Chemical structure diagram of Cyclobenzaprine Hydrochloride showing its molecular framework including rings and functional groups.*
FDA Label Image

Label Image (Lbl530020520)

Label Image (Lbl530020520)
Packaging label for Cyclobenzaprine Hydrochloride 5 mg tablets by RPK Pharmaceuticals, Inc., containing 30 tablets. The label instructs to take 1 tablet 3 times a day as needed or as directed. Includes cautions about drowsiness and alcohol use, with space for patient name, prescriber, and clinic information. Contains typical NDC numbers and lot details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.